A detailed history of Radnor Capital Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Radnor Capital Management, LLC holds 102,702 shares of PFE stock, worth $2.65 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares
102,702
Holding current value
$2.65 Million
% of portfolio
0.44%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$27.7 - $31.39 $2.84 Million - $3.22 Million
102,702 New
102,702 $2.97 Million
Q1 2024

Apr 11, 2024

SELL
$25.89 - $29.73 $74,174 - $85,176
-2,865 Reduced 3.22%
86,007 $2.39 Million
Q4 2023

Jan 11, 2024

BUY
$26.13 - $33.94 $304,022 - $394,891
11,635 Added 15.06%
88,872 $2.56 Million
Q3 2023

Oct 12, 2023

BUY
$32.09 - $37.51 $2.48 Million - $2.9 Million
77,237 New
77,237 $2.56 Million
Q1 2023

Apr 06, 2023

BUY
$39.39 - $51.28 $356,637 - $464,289
9,054 Added 18.14%
58,971 $2.41 Million
Q4 2022

Jan 09, 2023

BUY
$41.75 - $54.5 $75,859 - $99,026
1,817 Added 3.78%
49,917 $2.65 Million
Q3 2022

Oct 12, 2022

SELL
$43.76 - $53.42 $74,392 - $90,814
-1,700 Reduced 3.41%
48,100 $2.11 Million
Q2 2022

Jul 11, 2022

BUY
$46.53 - $55.17 $176,814 - $209,646
3,800 Added 8.26%
49,800 $2.61 Million
Q1 2022

Apr 25, 2022

SELL
$45.75 - $56.69 $16,836 - $20,861
-368 Reduced 0.79%
46,000 $2.38 Million
Q4 2021

Jan 20, 2022

BUY
$41.32 - $61.25 $1.92 Million - $2.84 Million
46,368 New
46,368 $2.74 Million
Q3 2021

Oct 26, 2021

SELL
$39.25 - $50.42 $2.01 Million - $2.59 Million
-51,298 Closed
0 $0
Q3 2020

Nov 02, 2020

BUY
$31.75 - $37.25 $142,811 - $167,550
4,498 Added 9.61%
51,298 $1.88 Million
Q2 2020

Jul 28, 2020

BUY
$30.12 - $36.54 $75,300 - $91,350
2,500 Added 5.64%
46,800 $1.58 Million
Q1 2020

Apr 07, 2020

SELL
$27.03 - $38.62 $148,151 - $211,676
-5,481 Reduced 11.01%
44,300 $1.45 Million
Q4 2019

Jan 10, 2020

SELL
$32.92 - $37.36 $75,716 - $85,928
-2,300 Reduced 4.42%
49,781 $1.95 Million
Q3 2019

Oct 07, 2019

BUY
$32.49 - $42.13 $25,992 - $33,704
800 Added 1.56%
52,081 $1.87 Million
Q2 2019

Jul 18, 2019

SELL
$36.98 - $41.52 $104,542 - $117,377
-2,827 Reduced 5.22%
51,281 $2.22 Million
Q1 2019

Apr 25, 2019

BUY
$37.5 - $41.2 $45,000 - $49,440
1,200 Added 2.27%
54,108 $2.3 Million
Q4 2018

Jan 16, 2019

BUY
$38.47 - $43.86 $4,962 - $5,657
129 Added 0.24%
52,908 $2.31 Million
Q3 2018

Oct 04, 2018

BUY
$34.47 - $41.81 $14,132 - $17,142
410 Added 0.78%
52,779 $2.33 Million
Q2 2018

Jul 10, 2018

BUY
$32.98 - $35.16 $6,595 - $7,031
200 Added 0.38%
52,369 $1.9 Million
Q1 2018

Apr 20, 2018

SELL
$31.91 - $37.02 $16,210 - $18,806
-508 Reduced 0.96%
52,169 $1.85 Million
Q4 2017

Feb 02, 2018

BUY
$33.26 - $35.29 $43,238 - $45,877
1,300 Added 2.53%
52,677 $1.91 Million
Q2 2017

Aug 09, 2017

BUY
N/A
51,377
51,377 $1.73 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $145B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Radnor Capital Management, LLC Portfolio

Follow Radnor Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Radnor Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Radnor Capital Management, LLC with notifications on news.